Vikas Sharma

Mr. Vikas Sharma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2025 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
VSVikas Sharma
Vikas Sharma
SKSandeep Kumar
Sandeep Kumar
RKRahul Kaushik
Rahul Kaushik
SPShaivi Parashar
Shaivi Parashar
This study investigates the anticancer and antioxidant potential of a novel phytochemical combination of eugenol, a natural compound extracted from cloves, and Sanguinarine, a flavonoid from Sanguinaria canadensis. The synergistic interaction between eugenol and Sanguinarine was found to exhibit moderate cytotoxicity against MCF-7 cell lines, with an IC50 value of 147.2 μM, suggesting potential anti-cancer properties. The combination also demonstrated potent antioxidant activity, comparable to quercetin, in DPPH and H2O2 scavenging assays. The results suggest that the eugenol-Sanguinarine combination may have therapeutic applications in the prevention and treatment of oxidative stress-related diseases and cancer. Further studies are needed to fully elucidate the mechanisms of action and optimal dosing regimens. Overall, this study highlights the potential of combining natural compounds to create novel antioxidant and anti-cancer agents, and underscores the importance of continued research into the therapeutic properties of plant-derived compounds.

22 January 2026 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
RKRAJAN KUMAR Kurmi
RAJAN KUMAR Kurmi
SSSnigdha Srivastava
Snigdha Srivastava
VSVikas Sharma
Vikas Sharma
Single-atom catalysts (SACs) have emerged as a powerful class of nano-catalysts for tumor therapy due to their well-defined active sites and exceptional ca